Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Road Ventures is a Geneva, Switzerland-based venture capital firm founded in 2017 that concentrates on the transportation and mobility sector. It invests in early-stage companies, typically in seed to Series A rounds, with the aim of accelerating innovative solutions that address the future of mobility. The firm provides capital and strategic support to entrepreneurs, helping them scale operations, navigate regulatory environments, and bring new mobility technologies to market. Its portfolio includes Alto, a rider services platform; Gestoos, which applies AI to enhance travel safety and user experience while respecting privacy; MotionTag, an operating system for tracking travel patterns; Zoov, an e-bike sharing concept; Zeleros, developing high-speed sustainable transport solutions; and Caura, a platform for vehicle ownership payments. Road Ventures seeks to shape the next generation of mobility by backing ambitious founders and guiding their growth.

Reuben Brothers is a Geneva, Switzerland-based family office founded in 2002, pursuing private equity and venture capital investments while excluding real estate development from its portfolio and engaging in debt financing.

Established in 2021 and headquartered in Geneva, Switzerland, Tayssir Capital is an investment firm specializing in venture capital. It focuses on investments within the digital assets sector.

Blufolio is a Swiss-based blockchain venture capital firm founded in 2018 and headquartered in Versoix. It invests in technology companies advancing blockchain and sustainability, including equity and token opportunities, with activities centered in Geneva and Switzerland. The firm employs a Luxembourg-registered fund structure to offer a diversified portfolio of blockchain startups to qualified investors globally, with partners such as Swisscom Blockchain, Zurich Insurance, and KPMG supporting portfolio companies.

Quadia is a Geneva-based investment firm specializing in impact investing. Founded in 2010, it provides equity and debt financing to institutional, private, and corporate clients, focusing on growth capital and direct investments in sustainable solutions. The firm targets sectors including circular products and materials, sustainable food and agriculture, energy efficiency and smart energy, mobility, health and nutrition, education, and urban infrastructure, and concentrates on Europe, with emphasis on France and Spain. Quadia employs an integrated impact management approach to generate attractive financial returns alongside positive social and environmental outcomes, aiming to support a regenerative economy. The firm operates with a dedicated team and seeks to enable financing for companies advancing the transition to sustainable development.

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Ginko Ventures is a venture capital firm founded in 2015 and based in Geneva, Switzerland. It targets technology companies across Europe and Israel, focusing on technologies, devices and solutions in connected objects, mobility, robotics, big data and artificial intelligence, with the aim of backing innovations that can rapidly reach global markets and improve how people work, play and live.

French Partners is a venture capital firm and co-investment platform founded in 2016 and based in Geneva, Switzerland. It operates as a co-investment club for qualified investors to back and support companies led by French entrepreneurs internationally. The firm targets startups and growing SMEs with revenues up to several tens of millions of euros and aims to accelerate their international presence. It typically makes minority investments ranging from €1 million to €5 million, either on its own or with co-investors.

Founded in 2019 and based in Geneva, Switzerland, Olive Capital is an angel network that provides its members access to investment opportunities in innovative, early-stage companies. Focusing primarily on the web3 sector, they leverage a deep global network of entrepreneurs to offer unique investment prospects.

Merck KGaA is a German science and technology company founded in Darmstadt in 1668. It operates in three main segments: Life Science, Electronics, and Healthcare, offering laboratory consumables and instruments, specialty materials for semiconductors, and branded pharmaceuticals with therapeutic focus areas such as oncology, multiple sclerosis and fertility. The group serves customers across Europe, Africa, Asia, Oceania and Latin America; in the United States and Canada the Merck name is owned by Merck & Co., so the German group uses regional branding in North America under EMD Millipore/EMD Chemicals. The Merck family retains a majority stake and the company has been publicly traded since 1995. Notable subsidiaries include Merck Consumer Healthcare and Merck Performance Materials. Known as the world's oldest operating chemical and pharmaceutical company, Merck KGaA emphasizes scientific exploration and responsible entrepreneurship as a long-standing global player in its sectors.

INKEF Capital is a venture capital firm based in Amsterdam, the Netherlands. It focuses on technology and healthcare, backing early-stage and Series A and growth-oriented companies across Europe. The firm pursues a patient, long-term investment approach and supports portfolio companies through multiple funding rounds as they scale. Its investments cover technology-driven sectors, including digital health, life sciences, biotechnology, enterprise software, fintech, and related fields, aiming to help entrepreneurs build successful international businesses from the Netherlands outward.

VI Partners is a Swiss venture capital firm based in Altendorf that specializes in funding healthcare, biotechnology, technology, and software companies across Switzerland and Europe. Founded in 2001, it supports high-growth startups through seed and Series A stages with capital, coaching, and networks, including involvement in university spin-offs. The firm focuses on building lasting value by pairing entrepreneurs with strategic expertise and industry insight to advance innovative companies.

Founded in 2017, DART Ventures is a Swiss venture capital firm investing in breakthrough technologies that positively impact health and climate. The company focuses on B2B, healthtech, foodtech, clean tech, and climate tech sectors across the U.S. and Europe. DART's unique approach includes a 12-month expansion program for startups, providing strategic guidance and access to experienced partners.

CDP Venture Capital is a venture capital fund manager active in Italy and Europe. It reports assets under management of 4.9 billion euros and invests directly and indirectly in innovative companies across sectors including AI and cybersecurity, green transition, and fintech. The firm builds an ecosystem that connects institutions, companies, universities, and research centers to support venture development and knowledge sharing. Investments are pursued through multiple funds and initiatives, reflecting a commitment to innovation, entrepreneurship, sustainable practices, and strategic partnerships within the Italian economy.

Omega Funds is a Boston-based venture capital firm founded in 2004 that focuses on funding early-stage healthcare and biotechnology companies in North America and Western Europe. The firm backs ventures across life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, seeking to advance therapies, platforms, and digital health solutions. With a seasoned team and extensive industry network, Omega Funds collaborates with exceptional founders to improve clinical and commercial success in the healthcare sector.

Syncona is a London-based life sciences investor focused on creating, building and scaling global leaders in health technology and medicine. It functions as the venture investing arm linked to The Wellcome Trust and concentrates on supporting startups and more mature ventures across the healthcare sector, with emphasis on gene therapy, targeted cell therapy, and advanced diagnostics. The firm pursues a global investment approach, typically committing between £1 million and £20 million per company and participates as a majority investor or in syndicates. Established in 2012, Syncona aims to partner with scientists and entrepreneurs to translate innovative science into transformative treatments and durable value for patients.

Gaingels is a venture capital organization focused on supporting LGBTQ+ founders and leaders and their allies. It invests across stages and industries, building a global portfolio of 130+ companies and deploying around $70 million in capital. Beyond funding, Gaingels helps portfolio companies recruit diverse C-suite and board talent and fosters a global community of investors, operators, and entrepreneurs working toward inclusive leadership and positive social change through business.

Amboy Street Ventures is a venture capital firm founded in 2021 and based in Los Angeles. It targets investments in fertility, sexual health, and women’s health technology startups, supporting companies advancing health tech in the United States and Europe.

Verve Ventures is a European venture capital firm and digital investment platform headquartered in Switzerland, with offices in Zurich, Lausanne, Berlin, Paris, and Cambridge. It connects qualified private investors, family offices, pension funds, and institutional partners with early-stage technology startups across Europe, offering funding and structured investment opportunities starting at modest thresholds. Founded in 2010, the firm screens thousands of startups annually, selecting a small top tier subset after due diligence, and supports portfolio companies with introductions, hiring assistance, and access to an expert network. Its investments span sectors including energy, computing, health, robotics, quantum computing, AI, digital health, data analytics, and clean energy and manufacturing. Verve Ventures emphasizes transparency and broad access to venture opportunities, aiming to reshape the European venture landscape through a technology-driven platform and a broad investor community.

OCCIDENT is an owner-managed venture capital firm that invests in deep tech start-ups, focusing on spin-offs from scientific research to enable real-world solutions. With offices in Munich and Zug, it supports early-stage companies in life sciences and industrial tech, and accompanies portfolio companies over the long term with financial backing and extensive operating experience. The firm invests its own money and makes decisions based on sustainable potential for success, aiming to contribute positively to society in a sustainable way. OCCIDENT collaborates closely with founding teams to tackle challenges, foster innovation, and drive long-term impact.

Mayo Clinic is a non-profit medical organization based in Rochester, Minnesota, established in 1863. It provides comprehensive medical care, education in clinical medicine and biomedical sciences, and conducts extensive medical research across a broad range of specialties. The organization integrates patient care with education and research to advance medical practice and outcomes. It also advances innovation through Mayo Clinic Platform, a Rochester-based accelerator that incubates and invests in early-stage health-tech startups in collaboration with providers, pharmaceutical and device companies, health-tech developers, and patients; and Mayo Clinic Ventures, the organization's venture arm that partners with physicians and scientists to commercialize inventions and discoveries to improve patient care and support Mayo’s education and research missions.

LIFTT is a venture capital holding company focused on deep tech investments across Europe with a global perspective. Founded in 2019 and based in Turin, Italy, it aims to translate scientific research into impactful businesses through a multi-vertical investment strategy spanning critical resources, human health, data infrastructure, energy security, and industrial automation. The firm backs technology companies and early-stage ventures, including Wearable Robotics and Vitrealab, and emphasizes ethical, sustainable practices and active collaboration to connect ideas, talent, and resources across its network. LIFTT seeks opportunities that advance research translation into commercial technologies.

Panakes Partners is a Milan-based venture capital firm founded in 2015 that makes early-stage investments in life sciences and healthcare companies across Europe and Israel. It supports ambitious teams developing innovative technologies and products in areas such as diagnostic equipment and healthcare technology systems, with the goal of improving patient outcomes and advancing medical solutions.

Spicehaus Partners is an independent Swiss venture capital firm based in Zug that backs early-stage technology companies in Switzerland, with an emphasis on B2B technology firms; founded in 2018 and owned by its partners, the firm combines investment experience with entrepreneurial expertise and actively supports its portfolio companies to promote growth, aiming to foster long-term partnerships between entrepreneurs and investors.

NEXT VENTŪRES is a venture capital firm founded in 2018 and located in Austin, Texas. The firm specializes in investments within the sports, fitness, nutrition, and wellness sectors. With a team that possesses extensive expertise and strong industry connections, NEXT VENTŪRES is equipped to generate substantial value for both its investors and portfolio companies.

ACE & Company is a Geneva-based private equity and venture capital firm with offices in London, Cairo, Hong Kong, and New York. It makes global private market investments across multiple stages and strategies, including angel, early, growth, mature, buyout, special situations, and secondaries, and engages in co-investments and leading or participating roles. The firm operates on a sector-agnostic basis, targeting opportunities across technology, financial services, healthcare, energy, consumer goods, and services, and seeks to deliver long-term value by tailoring investment exposure to each company's development stage and risk profile.

LGT Capital Partners is a global alternative investment manager based in Pfaeffikon, Switzerland. Established in 1994, the firm specializes in private markets and liquid alternatives, offering private equity, real estate, debt and hedge fund solutions, along with multi-asset and long-only programs for institutional clients. It serves pension funds, sovereign wealth funds, insurers and banks, and operates offices worldwide. The firm uses a bottom-up approach to manager selection and pursues opportunities across buyouts, growth and venture in private markets, including primary investments, co-investments and secondaries, as well as hedge funds and private equity fund of funds.

Paradigm is a crypto-focused investment firm based in San Francisco that funds early-stage companies and protocols in the cryptocurrency space. Founded in 2018 by Matt Huang and Fred Ehrsam, the firm emphasizes research as the core of its approach, aiming to advance crypto technology, economics, and the emergence of a new internet platform for money and governance. It acts as both investor and builder, developing open-source software and tools to push the frontier of crypto. The team collaborates on research papers and provides guidance on product and business strategy for ambitious projects at the frontier.

TeleSoft Partners is a venture capital investment firm founded in 1996 and based in Aspen, Colorado. It provides value-added capital and strategic support to technology, energy, and related sectors across the United States, helping entrepreneurs grow early-, mid-, and late-stage companies. The firm emphasizes leveraging its knowledge, contacts, and experience to accelerate growth and exits, and has participated in the development of more than 75 companies, with over 50 acquisitions or public offerings.

Section 32 is a California-based venture capital firm founded in 2017 by Bill Maris. It concentrates on early-stage investments in life sciences, healthcare, and technology across the United States. The firm seeks to back frontier technologies that accelerate discovery, development, and dissemination of transformative solutions that improve the human condition. Its investment scope spans artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology, with multi-million-dollar checks and a diversified portfolio of companies.

Athos Capital is a venture capital firm founded in 2016 and based in Madrid, Spain, that provides early-stage capital to technology companies across Europe, with a particular emphasis on Spain. It targets startups in areas including cloud-based farm management software, data storage, the Internet of Things, corporate accommodation platforms, and financial and educational technology.

Nauta Capital is a pan-European venture capital firm backing early-stage B2B software companies. Headquartered in London with offices in Barcelona and Munich, it operates across Europe and targets Series A to late seed and Series B investments in technology ventures. The firm focuses on B2B software with strong network effects, vertically oriented enterprise tech for large industries, and deep-tech applications that address enterprise challenges, including sectors such as retail tech, revenue tech, fintech, insurtech, health tech, enterprise software, developer tools, infrastructure, AI and ML, and security and privacy. With more than half a billion in assets under management and a team of around 20 professionals, Nauta is regarded as one of Europe’s larger B2B-focused investors.

Maverick Capital is a global investment firm established in 1993 that manages capital through long/short hedged equity strategies and private investments, with offices in New York, San Francisco, London, Hong Kong, Philadelphia and Dallas. The firm seeks to grow and preserve capital for qualified investors, conducting deep fundamental research and actively partnering with portfolio companies to support growth, including deploying resources and taking board seats. Maverick Capital also operates Maverick Ventures, its venture arm based in San Francisco, which funds startups from seed through growth across healthcare, software and deep technology, leveraging the parent firm’s resources and experience to help entrepreneurs build scalable businesses.

Ecosystem Ventures is a venture capital firm that provides seed-stage funding and strategic consulting to help startups build sustainable businesses around significant technologies and innovative ideas. It invests in seed rounds and supports founders toward the first major institutional investment (Series A), offering advisory services across American, Indian, and European markets. Founded in 2005, the firm is based in San Francisco.

Insight Partners is a global software investor that partners with growth-stage technology and software companies. Headquartered in New York City with offices in London, Tel Aviv, and Palo Alto, it concentrates on growth-stage software, internet, and data services, with notable focus areas including fintech, cybersecurity, AI/ML, DevOps, and healthcare. Founded in 1995, Insight Partners manages over $75 billion in regulatory assets under management and has invested in more than 750 companies worldwide, with over 55 portfolio companies achieving an IPO. The firm combines capital with hands-on, right-sized software expertise to support portfolio companies on their growth journey from first investment to IPO.

Gimv is a European investment company specializing in private equity and venture capital, founded in 1980 and headquartered in Antwerp, Belgium. It focuses on investments in business-to-business services, financial services, healthcare, information technology, technology, media and entertainment, telecommunications, manufacturing and life sciences, with activity across Belgium, France, Germany, the Netherlands and Switzerland. The firm manages a substantial portfolio, overseeing about 1.8 billion euros of investments across 85 portfolio companies, which together generate more than 6 billion euros in turnover and employ over 28,000 people.

123 Investment Managers is an independent investment firm based in Paris with offices in Lyon, specializing in private asset investments across venture capital, private equity, and fund of funds. It pursues direct investments in a broad range of stages from seed to mature growth and co-investment opportunities, primarily in technology, industry, renewable energy, and consumer sectors, and also in health-related and eldercare services, hotels, clinics, and other accommodation ventures. The firm focuses on Europe, with emphasis on France, Switzerland, the United States, and Canada, and targets portfolio company enterprise values roughly €5 million to €400 million, investing typically from about €0.8 million to €8 million per deal. It also offers multi-theme private asset strategies across tourism, healthcare, infrastructure, and real estate to help private and institutional clients access unlisted French companies and long-term value creation.

TPY Capital is a Tel Aviv-based venture capital and private equity firm founded in 2011 that invests in Israeli technology companies across early-stage to growth rounds, focusing on data and analytics, digitization and human augmentation, fintech, cloud infrastructure, enterprise software, machine learning, and frontier technologies such as quantum computing, seeking minority stakes and often leading rounds, and pursuing active, hands-on investments to support companies at pre-revenue and revenue stages with a focus on technology-enabled enterprise digitalization and productivity.

ProQuest Investments is a healthcare venture capital firm founded in 1998 that provides seed to late-stage financing to healthcare and biotechnology companies. The firm manages over $875 million in capital and operates offices in Princeton, San Diego, and Montreal. It has a focus on therapeutics and has investments across oncology, pain, and infectious disease, seeking long-term partnerships with entrepreneurs.

Global Finance is an independent investment firm founded in 1991 in Athens, Greece, and has been a pioneer of private equity and venture capital in Southeast Europe. Its operations include private equity fund management, real estate development, and advisory services, with equity investments in mid-market companies across sectors such as manufacturing, information technology, specialty retail, media and entertainment, healthcare, telecommunications, and services. The firm concentrates on opportunities in Greece and neighboring Southeast European markets and maintains a regional footprint with offices and activity in Sofia, Belgrade, Bucharest, and London. Typical investments are up to €40 million in Greece and up to €15 million for Eastern European ventures. Exit options include trade sales, initial public offerings, management buybacks, and sales to other investors. Global Finance aims to create value for investors and dynamic companies by supporting growth and improving operational performance in Southeast Europe.